News - Page 4 of 14 - Xtant Medical

Xtant Medical to Issue First Quarter 2023 Financial Results on May 4, 2023

April 27, 2023

BELGRADE, Mont. , April 27, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended

Xtant Medical Announces Fourth Quarter and Full Year 2022 Financial Results

March 7, 2023

BELGRADE, Mont. , March 07, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the fourth quarter and year ended

Xtant Medical to Issue Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023

March 3, 2023

BELGRADE, Mont. , March 03, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and

Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million

March 1, 2023

Expands Xtant’s Product Offering with the Leading PMA-Approved Intralaminar Stabilization Device Strengthens Surgalign’s Balance Sheet as it Embarks on its Digital Health Strategy BELGRADE, Mont. and DEERFIELD, Ill. , March 01, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc.

Xtant Medical to Present at the Canaccord Musculoskeletal Conference on March 7, 2023

February 28, 2023

BELGRADE, Mont. , Feb. 28, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne , Chief Executive Officer, will present at the Canaccord

Xtant Medical Appoints Mark Schallenberger as Chief Operations Officer

January 9, 2023

BELGRADE, Mont. , Jan. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Mark Schallenberger as Chief Operations Officer,

Xtant Medical Honors Donor Hero Asante Contreras on the Donate Life Rose Parade® Float

November 21, 2022

Company Sponsors Donate Life Float at Rose Parade for the Ninth Year BELGRADE, Mont. , Nov. 21, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, honors Asante

Xtant Medical Announces Third Quarter 2022 Financial Results

November 3, 2022

BELGRADE, Mont. , Nov. 03, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the third quarter ended September 30,

Xtant Medical to Issue Third Quarter 2022 Financial Results on November 3, 2022

October 27, 2022

BELGRADE, Mont. , Oct. 27, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended

Xtant Medical Announces Closing of Second Tranche of $9.75 Million Private Investment

October 11, 2022

BELGRADE, Mont. , Oct. 11, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of the second and final tranche of its previously announced

Xtant Medical Announces Closing of First Tranche of $9.75 Million Private Investment

August 31, 2022

BELGRADE, Mont. , Aug. 31, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of the first tranche of its previously announced private

Xtant Medical Announces $9.75 Million Private Investment

August 24, 2022

Upon completion of first closing, Stavros Vizirgianakis to become Non-Executive Chairman BELGRADE, Mont. , Aug. 24, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,